326030 logo

Sk Biopharmaceuticals Co Ltd (326030)

SK Biopharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders. The company offers Cenobamate, an anti-seizure medication for the treatment of epilepsy and Solriamfetol medication. It develops Carisbamate that is in Phase 3 trials to treat l...

KOHealthcareBiotechnologyKorea

Company Profile

Stock Code
326030
ISIN Code
KR7326030004
Currency
Korean Won (KRW)

Contact Information

Company Address
221, Pangyoyeok-ro, Seongnam-si, South Korea, 13494
Contact Phone
82 31 8093 0114
Company Website
https://www.skbp.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
15.98%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99